-
By product, specialty injectable pharmaceuticals (SIP) represented 63% of total net sales in 2012.
FORBES: Patient Investors Will Find The Right Prescription In Hospira
-
Calumet Specialty Product Partners LP shares are currently trading up about 3.3% on the day.
FORBES: Calumet Specialty Product Partners LP Stock Getting Very Overbought
-
One such company is Calumet Specialty Product Partners LP ( NASD: CLMT), which saw buying by Director George C.
FORBES: Connect
-
Calumet Specialty Product Partners LP shares are currently trading -0.16% on the day.
FORBES: Connect
-
The report also cited the strong quarterly dividend history at Calumet Specialty Product Partners LP, and favorable long-term multi-year growth rates in key fundamental data points.
FORBES: CLMT's Strong Dividend History Helps Get It To The Top 10
-
The notion of creating giant specialty stores that cater to a particular product segment has become a staple of the U.S. economy.
FORBES: Wal-Mart's Next Victims
-
Lots of need to move innovations through design, product development, marketing, derivative designs, prototype production, design for manufacturing, short-run specialty items and even prolific variation creation.
FORBES: Innovation Ain't So Easy Mr. President - Think Google, Not GE
-
Every PAC coffee farmer now meets Fair Trade Certified standards, allowing their product to be sold at a premium and quite possibly end up in the bottom of your cup of specialty coffee.
FORBES: Hope In Hell On Earth: Micro-Finance In Nicaragua
-
In the Specialty Materials segment, Corning anticipates fourth-quarter sales declines of about 15%, reflective across all product lines ncluding Gorilla Glass.
FORBES: Corning Q3 Tops Estimates